Insider Transactions in Q1 2023 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2023
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,599
-3.89%
|
$3,599
$1.68 P/Share
|
|
Feb 27
2023
|
Lisa Rojkjaer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,156
-4.29%
|
$2,156
$1.68 P/Share
|
|
Feb 25
2023
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+6.92%
|
-
|
|
Feb 25
2023
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,034
+12.5%
|
-
|
|
Feb 25
2023
|
Lisa Rojkjaer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,127
+7.59%
|
-
|
|
Feb 25
2023
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+3.66%
|
-
|